Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus propofol for sedation in mechanically ventilated ICU patients
ChiCTR2600133956Phase 4Not yet recruiting
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Jan 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam, propofol, fentanyl and dexmedetomidine in None (2 arms), sponsored by Taizhou Hospital of Zhejiang Province. Primary endpoint: Percentage of time without rescue sedation within the target sedation range. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
remimazolampropofolfentanyldexmedetomidine
Beyond the preview
Go deeper on ChiCTR2600133956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133956.